U.S. Markets close in 4 hrs 45 mins

Array BioPharma Inc. (ARRY)


NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
8.78-0.21 (-2.34%)
As of 11:15AM EDT. Market open.
People also watch
EXELARQLCLDXRIGLARIA
Full screen
Previous Close8.99
Open9.00
Bid8.72 x 1000
Ask8.73 x 1200
Day's Range8.66 - 9.10
52 Week Range3.10 - 13.40
Volume1,161,565
Avg. Volume3,640,104
Market Cap1.5B
Beta1.75
PE Ratio (TTM)-12.19
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Array BioPharma, Inc. breached its 50 day moving average in a Bullish Manner : ARRY-US : June 21, 2017
    Capital Cubeyesterday

    Array BioPharma, Inc. breached its 50 day moving average in a Bullish Manner : ARRY-US : June 21, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Array BioPharma, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bearish ... Read more (Read more...)

  • Capital Cube6 days ago

    ETFs with exposure to Array BioPharma, Inc. : June 16, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Array BioPharma, Inc. Here are 5 ETFs with the largest exposure to ARRY-US. Comparing the performance and risk of Array BioPharma, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Array BioPharma, Inc. :ARRY-US: Earnings Analysis: Q3, 2017 By the Numbers : June 14, 2017
    Capital Cube8 days ago

    Array BioPharma, Inc. :ARRY-US: Earnings Analysis: Q3, 2017 By the Numbers : June 14, 2017

    Categories: Yahoo FinanceGet free summary analysis Array BioPharma, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Array BioPharma, Inc. – Amgen Inc., Celgene Corporation, Albany Molecular Research, Inc., Astrazeneca PLC Sponsored ADR, Eli Lilly and Company, Onconova Therapeutics Inc., Cascadian Therapeutics Inc. and Novartis ... Read more (Read more...)